The Category That Carries It

Valerian's market is essentially the sleep and relaxation category, and it holds an unusual position within it: long-established, pharmacopoeially documented, and familiar to consumers who have never heard of most botanicals.

That familiarity is a real asset. Valerian needs no consumer education — which is why it survives in formulations where newer ingredients with better stories come and go.

The Format Problem

The most important market dynamic for a valerian buyer, and an awkward one.

Supplement demand across every category has migrated from capsules and tablets toward gummies, chewables and functional beverages. That shift is broadly good for the industry. It is specifically bad for valerian.

FormatCategory directionSuits valerian?
Capsules & tabletsDeclining shareYes — contains the odour
Gummies & chewablesGrowing fastPoorly — odour ceiling
Beverages & shotsGrowingPoorly without deodorisation

The commercial consequence: valerian's natural home is shrinking while the growing formats fight its chemistry. This has pushed demand toward deodorised grades and toward lower valerian inclusion within multi-botanical blends — where its familiarity carries label value without the dose that makes a gummy unpleasant. Brands that budget for deodorised material and bench the format early do fine; those that discover the odour ceiling at consumer testing do not. See formulation.

Where the Demand Sits

Multi-botanical sleep blends — the volume base

The largest application by some distance. Valerian appears alongside passionflower, lemon balm, chamomile, hops and ashwagandha, and very frequently with melatonin. Its role is often as much about consumer recognition as about inclusion level.

Single-ingredient sleep products

A steady traditional segment, particularly in European herbal-medicine channels where monograph-supported single-herb products have an established place.

Stress, tension and daytime calm

A secondary positioning at lower inclusion, competing directly with the adaptogen category — where ashwagandha has taken a great deal of the growth.

Women's wellness

Menopause comfort and restfulness formats, usually in combination. Smaller but growing.

Traditional herbal channels

Tinctures, teas and classical Western herbal preparations — the origin of the native-ratio extract grades still widely traded.

The Sourcing Geography Problem

Worth treating as a market fact rather than only a quality one, and we will be direct about it as an Indian exporter.

Botanical extract manufacturing has concentrated heavily in India and China. In India specifically, Indian valerian (Valeriana jatamansi, traded as tagar) is abundant and cheaper than imported V. officinalis.

So the geography that offers the best extract economics also carries the highest species risk — and the substitution is often entirely inadvertent, an order for "valerian" filled with the valerian that is locally available.

Two further species complicate the documentation: Mexican valerian (V. edulis), and Nardostachys jatamansi — spikenard, which is not a valerian at all and is CITES Appendix II listed, sharing only the epithet with Indian valerian.

The market's response has been weaker than it should be: a great deal of valerian still trades on extract ratio alone, which specifies neither species nor potency. See species substitution and authenticity.

Why This Is Fixable

Unusually, the market's central problem has a one-line solution.

Valerenic acids are characteristic of V. officinalis, so a valerenic acid specification verifies the species as a by-product of measuring potency. A buyer who specifies "valerenic acids NLT 0.8% by HPLC" has closed the substitution risk without commissioning any additional test.

That valerian's principal market risk persists despite so cheap a fix says more about specification habits than about supply.

Supply Characteristics

The Regional Picture

European Union

The most mature valerian market, with established herbal-medicine channels and monograph-supported products. Buyers here are generally the most rigorous on species. Standard import controls apply — MRLs, heavy metals, ETO.

United States

Large sleep-supplement demand under DSHEA, with the strongest migration toward gummies — and therefore the largest deodorised-grade requirement.

Asia-Pacific

Growing sleep-category demand, and a significant production region. The species question is most acute here.

India's Position

India has established extract manufacturing, NABL-accredited HPLC capability, and competitive economics.

It also has abundant V. jatamansi. Both facts are true, and a buyer is better served by a supplier who states them than by one who does not raise the subject. Qualify explicitly on species — the supplier guide weights it at 35 of 100 points for exactly this reason.

What This Means When You Buy

  1. Specify the binomial and valerenic acids. One line closes the market's central risk.
  2. Never buy on extract ratio alone, however traditional the format.
  3. Decide the format before the grade. Gummies and beverages need deodorised material and a real flavour budget.
  4. Consider lower inclusion in a blend rather than a high-dose single-ingredient format that fights its own chemistry.
  5. Ask about CITES wherever "jatamansi" appears in documentation.
  6. Budget for separated storage. The odour transfers, and cheap handling shows up later.
  7. Re-verify on origin change. That is where species change hides.

SV Botanica supplies Valeriana officinalis root extract from India with the species declared by binomial, valerenic acids assayed by HPLC on every batch, and deodorised grades for odour-sensitive formats. See the valerian product specification, the buyer's guide, or sleep and relaxation formulation.